Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

RMD

$229.949.05%-22.89

アフターアワーズ： 229.940.00 0.00%

Resmed Inc (RMD)

Date: O: H: L: C: Vol:

Resmed Inc (RMD) 最新ニュース

ResMed Inc. (NYSE:RMD) Shares Set to Pay Quarterly Dividend of $0.66 - MarketBeat

ResMed (NYSE:RMD) Stock Gets Price Target Bump from KeyCorp - MarketBeat

RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs - The Globe and Mail

Needham reiterates Hold on ResMed stock amid GLP-1 drug risks - Investing.com

What ResMed (RMD) Said on Its Q1 Earnings Call - Yahoo Finance

ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance

RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs - Zacks Investment Research

ResMed 3Q 2026: Revenue $1.41B, EPS $2.92— 10-Q Summary - TradingView

Profit rises at ResMed (RMD) alongside $855M in share buybacks. - Stock Titan

Resmed Inc. (ASX:RMD): Sleep Health Revenue and Fiscal Year Performance - Kalkine

Resmed Inc. (ASX:RMD): Quarterly Earnings Growth and MatrixCare Divestment - Kalkine

ResMed Inc (RMD) Q1 2027 Earnings Call Highlights: Revenue Climbs 7%, EPS Jumps 14%, and Record ... - Yahoo Finance

ResMed Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:RMD) 2026-10-30 - Seeking Alpha

ResMed revenue up 6% to $1.4B in Q1 FY27 - grafa.com

[ResMed Q1 2027 Earnings Call] ResMed Beats Q1 Estimates with 14% EPS Growth to $2.91, Returns Record $1 Billion to Shareholders but Reiterates Guidance - BigGo Finance

ResMed Inc. reports results for the quarter ended September 30 - Earnings Summary - TradingView

ResMed Fiscal Q1 Non-GAAP Earnings, Revenue Up - marketscreener.com

ResMed Q1 2027 Earnings Call Transcript - Benzinga

ResMed Fiscal Q1 Adjusted Earnings, Revenue Rise - www.marketscreener.com

ResMed (RMD) Beats Q1 Earnings and Revenue Estimates - Zacks Investment Research

ResMed: Fiscal Q1 Earnings Snapshot - Yahoo Finance

ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance

What Will ASX 50 Healthcare Stock ResMed (ASX:RMD) Reveal in Its Quarterly Update? - Kalkine Media

If You Invested $1000 In ResMed Stock 20 Years Ago, You Would Have This Much Today - Benzinga

All eyes on ResMed earnings as device dominance faces new tests By Investing.com - Investing.com South Africa

Are ResMed shares a strong buy before its results on Friday? - The Motley Fool Australia

Resmed Inc (ASX:RMD): What Do FY26 Earnings and a New CPAP Mask Mean for Its Sleep Health Business? - Kalkine

ResMed global general counsel sells $102,000 in company stock By Investing.com - Investing.com South Africa

Form 4 ResMed Inc: Michael J. Rider (Global General Counsel) For: 23 October - Investing.com Nigeria

ResMed Global General Counsel Michael Rider Sells 400 Shares at $255 Under 10b5-1 Plan - Kalkine

Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research

Resmed (ASX:RMD): FY26 Earnings, Sleep Health Products and Upcoming 1QFY27 Results - Kalkine

ResMed Inc. (RMD) options chain - Yahoo Finance Australia

ResMed Inc. (RMD) Stock Forecasts - Yahoo! Finance Canada

ResMed Inc. (RMD) Stock Forecasts - Yahoo! Finance Canada

Form 144 RESMED INC For: 23 October By Investing.com - Investing.com South Africa

Form 144 RESMED INC For: 23 October By Investing.com - Investing.com Canada

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research

ResMed Inc. Estimates – NYSE:RMD - TradingView

ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock? - Zacks Investment Research

ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock? - Yahoo Finance

ResMed Inc. (RMD) Stock forecasts - Yahoo Finance UK

ResMed Inc. (RMD) Stock forecasts - Yahoo Finance Singapore

ResMed Inc. stock rises Thursday, outperforms market - MarketWatch

ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance

ResMed Inc. (RMD) Stock Forecasts - Yahoo! Finance Canada

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Zacks Investment Research

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

ResMed Converts Physician Loyalty Into Pricing Power - Morningstar

ResMed's 18% Rally Meets A Thin Quarter As Astral And Margin Pressure Weigh - Finviz

RMDに類似

WST$412.620.97%

MDLN$32.120.38%

SOLV$81.332.67%